Login / Signup

Type 1 Diabetes Mellitus in the First Years of Life - Onset, Initial Treatment, and Early Disease Course.

J ZieglerS R TittelT BiesterT KapellenA DostN RochowD Seick BarbariniA BöhleA GallerR W Holl
Published in: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (2024)
Young children with T1D had high rates of DKA at onset and were predominantly treated with insulin pump therapy during the first 2 years. The median HbA1c for all three groups was<7.5% (58 mmol/mol) without increased risk of SH or DKA. The use of continuous glucose monitoring (CGM) was not associated with lower HbA1c in children under 48 months.
Keyphrases
  • glycemic control
  • type diabetes
  • mesenchymal stem cells
  • african american
  • replacement therapy